Publicaciones en colaboración con investigadores/as de Hospital General Universitario de Elche (10)

2022

  1. Considerations on diagnosis and surveillance measures of PTEN hamartoma tumor syndrome: clinical and genetic study in a series of Spanish patients

    Orphanet Journal of Rare Diseases, Vol. 17, Núm. 1

2018

  1. PDGFR and IGF-1R inhibitors induce a G2/M arrest and subsequent cell death in human glioblastoma cell lines

    Cells, Vol. 7, Núm. 9

2017

  1. Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain

    Clinical and Translational Oncology, Vol. 19, Núm. 6, pp. 667-681

2014

  1. Comparative study of 17-AAG and NVP-AUY922 in pancreatic and colorectal cancer cells: Are there common determinants of sensitivity?

    Translational Oncology, Vol. 7, Núm. 5, pp. 590-604

  2. Resistance to selumetinib (AZD6244) in colorectal cancer cell lines is mediated by p70s6K and RPS6 activation

    Neoplasia (United States), Vol. 16, Núm. 10, pp. 845-860

  3. Role of receptor tyrosine Kinases and their Ligands in glioblastoma

    Cells, Vol. 3, Núm. 2, pp. 199-235

2011

  1. Small tyrosine kinase inhibitors interrupt EGFR signaling by interacting with erbB3 and erbB4 in glioblastoma cell lines

    Experimental Cell Research, Vol. 317, Núm. 10, pp. 1476-1489

2007

  1. Inhibition of Hsp90 function by ansamycins causes downregulation of cdc2 and cdc25c and G2/M arrest in glioblastoma cell lines

    Oncogene, Vol. 26, Núm. 51, pp. 7185-7193

2006

  1. Cyclin D3 is down-regulated by rapamycin in HER-2-overexpressing breast cancer cells

    Molecular Cancer Therapeutics, Vol. 5, Núm. 9, pp. 2172-2181

2005

  1. Histone deacetylase inhibitors induced caspase-independent apoptosis in human pancreatic adenocarcinoma cell lines

    Molecular Cancer Therapeutics, Vol. 4, Núm. 8, pp. 1222-1230